Meningitis has been reported to be more frequent in patients treated with anti-CTLA4 and less common in anti-PD1/PD-L1, whereas myasthenia gravis and myositis are more often associated with anti-PD1/PD-L1 [159]. Here, PDCD1 is linked to myasthenia gravis.